Get the Stockscreener App
7.515
2.95%
0.215
After Hours:
7.66
0.145
+1.93%
Lipocine Inc Stock (LPCN) Forecast
The Lipocine Inc (LPCN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $5.9086, representing a -21.38% decrease from the current price of $7.515. The highest analyst price target is $9.9886, and the lowest is $1.8286.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LPCN Price Target
Average 11.52
(+53.31% Upside)
Is Lipocine Inc (LPCN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 80.74 | Sell |
| STOCH(9,6) | 87.63 | Sell |
| STOCHRSI(14) | 67.44 | Neutral |
| MACD(12,26) | 1.1499 | Buy |
| ADX(14) | 56.75 | Buy |
| William %R | -15.98 | Sell |
| CCI(14) | 95.92 | Neutral |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.2455
Buy
|
6.4513
Buy
|
| MA20 |
4.8533
Buy
|
5.4189
Buy
|
| MA50 |
3.7169
Buy
|
4.2394
Buy
|
| MA100 |
3.3449
Buy
|
3.7112
Buy
|
| MA200 |
3.2884
Buy
|
3.6389
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, LPCN could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 3 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on LPCN, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 80.74 indicates that LPCN is overbought. This suggests that LPCN price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 87.63 indicates that LPCN is oversold. This means that LPCN price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 67.44 indicates that LPCN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 56.75 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 95.92 indicates that LPCN is still overbought but not to an extreme extent.
Long-term LPCN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lipocine Inc financial reports and earnings history, Lipocine Inc (LPCN) stock could reach $26.15 by 2030, $21.12 by 2040 and $48.83 by 2050. See the projected annual prices until 2050 of the Lipocine Inc stock below:
- Lipocine Inc (LPCN) is expected to reach an average price of $9.7973 in 2035, with a high prediction of $10.34 and a low estimate of $9.8973. This indicates an $30.37% rise from the last recorded price of $7.515.
- Lipocine Inc (LPCN) stock is projected to chart a bullish course in 2040, with an average price target of $21.85, representing an $190.77% surge from its current level. The forecast ranges from a conservative $21.74 to a sky-high $21.12.
- Our analysts predict Lipocine Inc (LPCN) to jump 397.95% by 2045, soaring from $37.46 to an average price of $37.42, potentially reaching $37.11. While $37.46 is the low estimate, the potential upside is significant.
- Lipocine Inc (LPCN) stock is expected to climb by 2050, reaching an average of $42.07, a $459.86% jump from its current level. However, a wide range of estimates exists, with high and low targets of $48.83 and $45.30, respectively, highlighting the market's uncertainty.
Lipocine Inc Stock (LPCN) Year by Year Forecast
Lipocine Inc Stock (LPCN) Price Forecast for 2026
The predicted value for Lipocine Inc (LPCN) in 2026 is set at an average of $11.18. Estimates vary from a peak of $22.18 to a trough of $0.1783, indicating an +48.75% surge from the present price of $7.515.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2026 | $3.9454 | $1.8286 | $9.9886 | -47.50% |
| March, 2026 | $8.5022 | $2.2288 | $11.56 | +13.14% |
| April, 2026 | $11.61 | $9.089 | $22.18 | +54.44% |
| May, 2026 | $10.04 | $2.5793 | $14.29 | +33.64% |
| June, 2026 | $8.1396 | $4.7562 | $10.97 | +8.31% |
| July, 2026 | $4.4432 | $3.5932 | $8.8963 | -40.88% |
| August, 2026 | $5.2601 | $1.0267 | $7.3167 | -30.01% |
| September, 2026 | $6.1537 | $4.5038 | $8.8737 | -18.11% |
| October, 2026 | $6.3756 | $3.2306 | $7.7934 | -15.16% |
| November, 2026 | $5.9175 | $5.5775 | $8.9173 | -21.26% |
| December, 2026 | $2.4761 | $1.4644 | $6.3342 | -67.05% |
Lipocine Inc Stock (LPCN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lipocine Inc (LPCN) is $9.2327, with a high forecast of $18.39 and a low forecast of $0.0794. This indicates an +22.86% increase from the last price of $7.515.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.273 | $0.8632 | $5.588 | -69.75% |
| February, 2027 | $4.5348 | $1.4011 | $5.3081 | -39.66% |
| March, 2027 | $3.5584 | $1.3276 | $5.1817 | -52.65% |
| April, 2027 | $2.2605 | $1.1504 | $4.4686 | -69.92% |
| May, 2027 | $1.9792 | $0.1142 | $3.4922 | -73.66% |
| June, 2027 | $11.53 | $1.891 | $11.53 | +53.37% |
| July, 2027 | $9.6227 | $8.0927 | $18.39 | +28.05% |
| August, 2027 | $3.422 | $3.1313 | $9.9544 | -54.46% |
| September, 2027 | $1.6449 | $0.1335 | $5.5863 | -78.11% |
| October, 2027 | $1.0746 | $0.1651 | $3.4033 | -85.70% |
| November, 2027 | $0.9412 | $0.6126 | $2.2121 | -87.48% |
| December, 2027 | $0.0141 | $0.0794 | $2.2238 | -99.81% |
Lipocine Inc Stock (LPCN) Price Forecast for 2028
In 2028, Lipocine Inc (LPCN) is projected to reach an average price of $46.53, with a high projection of $92.23 and a low estimate of $0.8378. This indicates an +519.20% rise from the last price of $7.515.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.9843 | $1.8727 | $1.4726 | -73.60% |
| February, 2028 | $3.7157 | $2.8991 | $3.0119 | -50.56% |
| March, 2028 | $4.0291 | $3.8255 | $3.6721 | -46.39% |
| April, 2028 | $2.573 | $3.3465 | $3.7331 | -65.76% |
| May, 2028 | $3.3947 | $3.4668 | $2.5978 | -54.83% |
| June, 2028 | $0.8047 | $1.1447 | $3.0477 | -89.29% |
| July, 2028 | $0.6848 | $0.8378 | $0.6513 | -90.89% |
| August, 2028 | $4.0667 | $1.6111 | $1.4249 | -45.89% |
| September, 2028 | $3.5473 | $3.7941 | $3.1158 | -52.80% |
| October, 2028 | $4.5495 | $4.0705 | $3.759 | -39.46% |
| November, 2028 | $3.7968 | $3.8635 | $92.23 | -49.48% |
| December, 2028 | $2.95 | $3.2566 | $3.2401 | -60.75% |
Lipocine Inc Stock (LPCN) Price Forecast for 2029
The 2029 price forecast for Lipocine Inc Stock (LPCN) is $10.44 on average, with a high prediction of $20.81 and a low estimate of $0.0692. This represents an +38.94% increase from the previous price of $7.515.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.6364 | $3.1464 | $3.2785 | -64.92% |
| February, 2029 | $3.1495 | $2.6129 | $2.7595 | -58.09% |
| March, 2029 | $3.3526 | $3.3526 | $3.066 | -55.39% |
| April, 2029 | $3.8657 | $3.6959 | $3.7024 | -48.56% |
| May, 2029 | $3.8021 | $3.9488 | $3.9436 | -49.41% |
| June, 2029 | $3.3652 | $3.5652 | $3.5391 | -55.22% |
| July, 2029 | $2.8983 | $3.1751 | $3.1885 | -61.43% |
| August, 2029 | $1.4047 | $1.5797 | $2.5917 | -81.31% |
| September, 2029 | $1.1879 | $1.1546 | $1.13 | -84.19% |
| October, 2029 | $0.5742 | $0.7342 | $0.9311 | -92.36% |
| November, 2029 | $0.9626 | $0.0692 | $2.7659 | -87.19% |
| December, 2029 | $21.85 | $0.1694 | $20.81 | +190.70% |
Lipocine Inc Stock (LPCN) Price Forecast for 2030
Lipocine Inc Stock (LPCN) is expected to reach an average price of $21.76 in 2030, with a high forecast of $41.79 and a low forecast of $1.7309. This signifies an +189.58% surge from the last price of $7.515.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $24.64 | $22.87 | $26.15 | +227.82% |
| February, 2030 | $19.94 | $20.11 | $20.57 | +165.36% |
| March, 2030 | $20.35 | $20.16 | $19.45 | +170.77% |
| April, 2030 | $1.2995 | $6.9843 | $17.81 | -82.71% |
| May, 2030 | $2.8171 | $1.7309 | $8.1126 | -62.51% |
| June, 2030 | $4.0733 | $2.5268 | $5.9732 | -45.80% |
| July, 2030 | $41.66 | $3.0864 | $40.88 | +454.38% |
| August, 2030 | $42.20 | $41.57 | $41.79 | +461.48% |
| September, 2030 | $39.27 | $40.33 | $41.25 | +422.50% |
| October, 2030 | $38.63 | $38.88 | $38.35 | +414.06% |
| November, 2030 | $39.45 | $37.23 | $37.54 | +425.01% |
| December, 2030 | $38.16 | $37.97 | $37.98 | +407.84% |
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):